肝细胞癌
肿瘤微环境
免疫疗法
生物
免疫系统
质量细胞仪
癌症研究
肿瘤相关巨噬细胞
免疫学
计算生物学
表型
遗传学
基因
作者
Huakan Zhao,Ran Ren,Xi Zhang,Mengtao Zhan,Jinwei Cui,Jun Zhang,Xi Liu,Lei Wu,Yu Chen,Yu Zhou,Yang Xiao,Jiangang Zhang,Yang Chen,Lu Zheng,Bing Sun,Yongsheng Li
标识
DOI:10.1158/2326-6066.cir-24-1298
摘要
Abstract Analysis of posttranslational modifications (PTM) of proteins can provide new insights, beyond those obtained from analysis of protein levels, for understanding the tumor microenvironment (TME). The characteristics of PTMs in immune cells, along with their spatial distribution, have not been comprehensively integrated, which impedes our understanding of the complexity and heterogeneity of the TME in hepatocellular carcinoma (HCC). In this study, we used a strategy that combines antibodies for specific PTMs with mass cytometry and mass spectrometry technologies to identify PTMs at single-cell resolution. We found that the phosphorylation status of M2 macrophages was substantially altered in tumor tissues from patients with hepatitis B virus (HBV)–positive HCC. Utilizing the expression profiles of site-specific phospho–heat shock protein 27, signal transducer and activator of transcription 1, and tripartite motif–containing protein 28, we classified M2 macrophages into four distinct subtypes: M2-P0 (absence of any of the three phospho-proteins), M2-P1 (presence of one of the three phospho-proteins), M2-P2 (presence of two of the three phospho-proteins), and M2-P3 (presence of all three phospho-proteins). The spatial relationships and functional characteristics of these M2 macrophage subpopulations were assessed using single-cell PTM omics. The abundance of the M2-P2 and M2-P3 subtypes was closely associated with an immunosuppressive TME and responsiveness to immunotherapy in HBV+ HCC. Overall, this study introduces a single-cell PTM-omics approach that uncovers subtypes of macrophages associated with immunotherapeutic responses in HBV+ HCC and provides valuable insights into the immunosuppressive TME of HCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI